MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    The prevalence of constipation and irritable bowel syndrome in Parkinson’s disease patients according to Rome III diagnostic criteria

    T. Mishima, J. Fukae, S. Fujioka, K. Inoue, Y. Tsuboi (Fukuoka, Japan)

    Objective: To assess the prevalence of constipation and irritable bowel syndrome (IBS) in Parkinson's disease (PD) patients using Rome III in our cohort. Background: Gastrointestinal…
  • 2016 International Congress

    Comprehensive motor and non-motor staging system in Parkinson’s disease: Results from a global cross-sectional study

    C. Rodriguez-Blazquez, A. Rizos, K.R. Chaudhuri, P. Martinez-Martin, NILS, EUROPAR and MDS Non-Motor PD Study Groups (Madrid, Spain)

    Objective: To describe a sample of Parkinson's disease (PD) patients by means of a combined, comprehensive, motor and non-motor staging system. Background: PD severity is…
  • 2016 International Congress

    Use of the physiotherapy in the treatment of initial stages of Parkinson’s disease

    O.L. Tondiy (Kharkiv, Ukraine)

    Objective: Stage of Parkinson's disease was determined by the Hoehn&Yahr Scale. Background: The effect of the low-frequent variable magnetic field, the ultratonetherapy and balneotherapy on…
  • 2016 International Congress

    Survey of prodromal symptoms of Parkinson’s disease in Japan

    M. Yogo, M. Morita, M. Suzuki (Katsushika-ku, Japan)

    Objective: To reveal prodromal symptoms at a public seminar for PD via questionnaires. Background: How to select subjects with PD for disease modify therapy in…
  • 2016 International Congress

    A case series of sigmoid volvulus in Parkinson’s disease

    K. Khalid, A. McColl, M. Gosney, A.K. Chatterjee (Reading, United Kingdom)

    Objective: To study the outcomes of patients with Parkinson's disease (PD) who were admitted with a diagnosis of sigmoid volvulus. Background: Constipation is a common…
  • 2016 International Congress

    Inhibition of nociceptive responses by modulating serotonergic signals at the rostral ventromedial medulla in 6-OHDA-induced Parkinson’s disease rat model

    C. Wang, C. Mao, F. Wang, J. Yang, X. Zhang, Y. Yang, C. Liu (Suzhou, People's Republic of China)

    Objective: We aimed to determine whether the descending 5-HT facilitatory pathway from rostral ventromedial medulla (RVM) and the extracellular 5-HT in RVM are involved in…
  • 2016 International Congress

    Orthostatic intolerance and falls in Parkinson’s disease

    A. Fanciulli, C. Dallinger, G. Goebel, R. Granata, S. Duerr, F. Sprenger, F. Krismer, C. Mueller, S. Boesch, M. Nocker, C. Scherfler, K. Seppi, W. Poewe, G.K. Wenning (Innsbruck, Austria)

    Objective: Primary objective: to assess the relationship between falls, orthostatic intolerance and orthostatic hypotension (OH) in patients with Parkinson's disease (PD). Secondary objective: to assess…
  • 2016 International Congress

    Impaired hippocampal neurogenesis associates with serotonergic axonal degeneration in transgenic rat and mouse models of Parkinson’s disease

    Z. Kohl, J. Deußer, D. Amato, C.P. Müller, O. Riess, E. Masliah, S. Nuber, J. Winkler (Erlangen, Germany)

    Objective: To evaluate the impact of α-synuclein accumulation on the hippocampal serotonergic system and hippocampal plasticity in two different α-synuclein expressing rodent models. Background: Parkinson's…
  • 2016 International Congress

    Awareness and perception of gastrointestinal symptoms in Parkinson´s disease: A survey of patients and caregiving relatives

    P. Themann (Halsbrücke, Germany)

    Objective: The purpose of this survey was to determine the awareness and perception of gastrointestinal (GI) symptoms in patients and caregiving relatives (for simplicity hereunder…
  • 2016 International Congress

    Assessment of gait dysfunction in patients with Parkinson’s disease and REM behavioral disorder

    L.R. Niemand, A. Dang, C. Singer, C.C. Luca (Miami, FL, USA)

    Objective: To determine if Parkinson's disease patients with REM behavioral disorder (RBD) have worse gait abnormalities and freezing of gait when compared to those without…
  • « Previous Page
  • 1
  • …
  • 1541
  • 1542
  • 1543
  • 1544
  • 1545
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley